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Abstract
The thesis entitled "Design and Combinatorial Synthesis of Pyrrolobenzodiazepine Antitumour Antibiotics" has been divided in to four chapters. Chapter-I deals with general introduction about cancer chemotherapy, drug-DNA interactions, solid-phase synthesis, pyrrolobenzodiazepine antitumour antibiotics and the aim and objectives of the present work. Chapter-II consists of design and solid-phase synthesis of N10-substituted pyrrolo[2,1-c][1,4]benzodiazepine-5,11-diones and development of a new methodology for nitro reduction on solid supports and its application to the solid-phase synthesis of 2-hydroxy pyrrolo[2,1-c][1,4]benzodiazepine-5,11-diones and their analogues. Chapter-III deals with the solid-phase synthesis of DNA-interactive 2-hydroxy pyrrolo[2,1-c][1,4]benzodiazepine imines. Chapter-IV deals with the synthesis of new 2-azido pyrrolo[2,1-c][1,4]benzodiazepine imine and 2-azido/amino pyrrolo[2,1-c][1,4]benzodiazepine-5,11-diones employing selective aromatic azido reduction with hexamethyldisilathiane. 
Chapter-I: General Introduction 
Cancer is one of the dreadful diseases, which remained as a challenging problem. The abnormal rapid growth of cancer cells compared to normal cells provides an opportunity to be exploited for the development of chemotherapy. Several distinct class of anticancer drugs are now being used in chemotherapy and are generally termed as antineoplastic agents. These include DNA topoisomerase I and II inhibitors, antimitotic agents, DNA-interactive agents and other miscellaneous compounds. The pyrrolo[2,1-c][1,4]benzodiazepines (PBDs) have potential as regulators of gene expression with possible therapeutic application in the treatment of genetic disorders including cancers, as selective anti-ineffective agents, and as probes and tools for use in molecular biology. The naturally occurring pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumour antibiotics are anthramycin, tomaymycin, chicamycin, DC-81, abbeymycin, prothramycin, and sibiromycin. The mechanism of action of the PBDs is associated with their ability to form an adduct in the minor groove, thus interfering in DNA replication. After insertion in the minor groove, an aminal bond is formed through nucleophilic attack of the N2 of guanine base at the C11 position of PBD imines. One of the major goals in medicinal chemistry is the identification of high affinity and activity ligands that interact to the receptors and enzymes. To address a growing demand for new compounds, several programs in medicinal chemistry exploit combinatorial methods by using simultaneous or parallel synthesis of libraries. The favorable pharmocokinetic properties of many small organic molecules the design, synthesis and evaluation of libraries has rapidly become a major frontier in organic chemistry. The use of solid-phase synthesis for the generation of diverse libraries of small organic molecules have been extensively employed in the drug discovery process that provide lead compounds. There are various advantages of strategies based on solid-phase organic synthesis. For instance an excess of soluble reaction partner accelerates the reaction, thus the complete conversion can be achieved. Similarly, simple washing of the support at the end of each reaction eliminates complex workup and purification steps. Thus solid-phase synthesis enables full automation of all steps even for multiple-step synthesis. In view of this, it has been considered of interest to synthesize PBD libraries on solid supports to develop a variety of compounds with structural modifications and to evaluate their anticancer potential. 
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Chapter-II: Solid-Phase Synthesis of Pyrrolo[2,1-c][1,4]benzodiazepine-5,11-diones 
In the naturally occurring PBDs, the imine or carbinolamine functionality at N10-C11 position is primarily responsible for covalent binding with DNA. The analogous PBD dilactams, that has an amide bond at N10-C11 position also exhibited significant antibiotic activity through non-covalent groove binding to DNA. Further, these compounds possess a broad spectrum of biological activity such as antiphase activity, analgesic antagonist, anti-inflammatory, psychomotor depressant activity and sedative activity. There are different methods known for the solution-phase synthesis of these tricyclic PBD-5,11-diones. However, the solid-phase synthesis of these biologically important compounds has not been examined. Nevertheless, there are numerous reports on the solid supported preparation of bicyclic 1,4-benzodiazepine-2,5-diones. 
Section-A: Solid Phase Synthesis of N10-subsitituted PBD-5,11-diones 
The preclinical trials of N10-substituted PBD-5,11-diones possessing anxiolytic activity have been carried out and are found to be invariably more active than the corresponding N10-unsubstituted analogues. Solid-phase synthesis of N10-substituted PBD-5,11-diones has been carried out by employing the Wang resin. 2-Nitro 3- or 4-hydroxy methylbenzoate (1) is coupled with Wang resin by the Mitsunobu protocol employing diisopropyl azodicarboxylate (DIAD), triphenyl phosphine (TPP) in N-methyl pyrrolidone (NMP) to give 2. Hydrolysis of the methylester afforded the corresponding acid, which was coupled with proline methylester in the presence of DCC and DMAP to provide the precursor 4. Reductive cyclization of 4 afforded the desired PBD 5,11-dione (5), which upon cleavage from the resin provided 8- or 9-hydroxy substituted PBD 5,11-dione (7). Furthermore, reaction of 5 with different alkyl or benzyl or allyl halides afforded N10-substituted PBD 5,11-diones (6) and this upon cleavage from the resin provided N10-substituted PBD 5,11-diones (7) as shown in Scheme 1. 
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This is a straightforward solid-phase synthesis of PBD 5,11-diones which permits introduction of a diverse array of substituents into both the aromatic portion and N10-position of the PBD 5,11-dione skeleton. Hence, this synthetic sequence allows the generation of the combinatorial library of these biologically important class of compounds (Bioorg. Med. Chem. Lett., 2001, 11, 387). 
Section-B: Efficient Reduction of Aromatic Nitro/Azido Groups on Solid Support Employing Indium: Synthesis of 2-Hydroxy Pyrrolo[2,1-c][1,4]benzodiazepine-5,11-diones 
Recently, the generation of compound libraries through combinatorial methods has received tremendous attention mainly as a means of accelerating the drug discovery process. In this connection, the development of new solid-phase methodologies is a significant and essential part of increasing the range of compounds, which could be achieved by this approach. In solution phase chemistry, the aromatic nitro and azido groups have been reduced by a variety of reagents. However, a large number of these methods are not suitable for application in solid phase organic chemistry. The most common method presently in use for the reduction of solid-phase bound nitro and azido groups utilizies tin (II) chloride. In spite of the advantages of tin reduction there are instances in the literature where substantial quantities of tin by-products remain bound within the resin matrix and are liberated upon acidic cleavage of the desired product. Furthermore, most of the cell lines employed for biological screening have proven intolerant to tin at these levels. Attempts to wash any residual tin remaining within the resin by employing different methods have only been partly successful. Figure (​http:​/​​/​www.csirexplorations.com​/​images_et​/​a87_figureNO3.jpg" \t "_blank​) 
The present method describes a useful and high yielding solid-phase synthesis of PBD-5,11-diones employing indium/NH 4 Cl, which works in neutral conditions and is specific to the reduction of nitro and azido groups in the presence of other functionalities. DBU was added to a suspension of Wang resin (8) and trichloroacetonitrile to give TCA-resin (9) which has been coupled with azidoester (10) in presence of trifluoremethanesulphonic acid to provide the precursor 11. Compound 10 has been prepared from 2-nitro/azido benzoic acids as shown in Scheme-2. Reductive cyclization of 11 with indium/NH 4 Cl in EtOH or DMF afforded the PBD-5,11-diones (12) and this upon cleavage from the resin provided 2-hydroxy PBD-5,11-diones (13) (Scheme-3) (Tetrahedron Lett., 2001, 41, 6969). 
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Chapter-III: Solid-Phase Synthesis of DNA-interactive 2-Hydroxy Pyrrolo[2,1-c][1,4]benzodiazepine Antitumour Antibiotics 
There are many methods known for the solution-phase synthesis of PBD imines. However, there is only one report on the solid-phase synthesis of these PBD antitumour antibiotics involving an oxidation/cyclization procedure based on the Fukuyama methodology employing p-nitrophenyl carbonate Wang resin. This chapter describes an efficient solid-phase synthesis of N10-c11 imine containing 2-hydroxy substituted PBD ring system and their dilactams of biological interest has been described. It is well known in the literature that C-ring hydroxy substitution plays an important role in their biological activity for example as in some of the naturally occurring PBDs such as chicamycin A and B, neothramycin A and B and abbeymycin. The present synthetic strategy is partly based on the solution-phase approach that involves the reductive cyclization. In the first step, the Wang trichloroacetamidate resin (17), prepared by Hanessian protocol was coupled with Fmoc protected 4-hydroxyproline methylester (16) which has been prepared from L-hydroxy proline (14) as shown in Scheme-4. This after Fmoc deprotection using 20% piperidine/DMF, was coupled with 2-azidobenzoic acid in the presence of DCC and DMAP to provide the amide 21. Reductive cyclization of 21 using TPP afforded the PBD-5,11-diones, which upon cleavage from the resin yielded 2-hydroxy-7,8-substituted PBD-5,11-diones. Furthermore, the reduction of 21 by DIBAL-H followed by reductive cyclization and cleavage afforded 2-hydroxy-7,8-substituted PBD imines (24) as illustrated in Scheme 5. Figure (​http:​/​​/​www.csirexplorations.com​/​images_et​/​a87_figureNO5.jpg" \t "_blank​) This is a practical solid-phase synthesis of pyrrolo[2,1-c][1,4]benzodiazepines and their dilactams. It is interesting to note that diversity on the aromatic A-ring could be introduced by using various azido benzoic acids. This methodology allows the generation of combinatorial library of not only PBD imines but also PBD-5-11-diones (Tetrahedron Lett., 2002, 42, 2103). Figure (​http:​/​​/​www.csirexplorations.com​/​images_et​/​a87_figureNO6.jpg" \t "_blank​) 
Chapter-IV: Synthesis of New 2-Azido Pyrrolo[2,1-c][1,4]benzodiaze pine: Selective Aromatic Azido Reduction with HMDST 
There has been increasing interest in discovery and development of small molecules that are capable of interacting with nucleic acids in a sequence-selective manner. Such compounds have potential in the therapy of genetic-based diseases (some cancers), diagnostics and validation of DNA sequences. The pyrrolo[2,1-c][1,4]benzodiazepines are well known class of antitumour antibiotics with sequence-selective DNA binding ability. The PBDs have also been used as a scaffold to attach EDTA and epoxide moieties, leading to novel sequence-selective DNA cleaving and crosslinking agents, respectively. Recently, new cross-linking PBD dimers (SJG-136) having C2/C2'-exo unsaturation have been recently prepared and reported the literature that exhibit extraordinary DNA binding affinity. The objective of the present work is to prepare a new class of minor groove binders by inserting azido group at C2 position. In this effort 2-azido pyrrolo[2,1-c][1,4]benzodiazepines have been synthesized employing hexamethyldisilathiane (HMDST). Earlier reported procedure for 2-azido/amino-PBD-5,11-diones has several limitations. This chapter, describes an efficient synthesis of 2-azido/amino PBD-5,11-diones using selective aromatic azido group reduction with HMDST and indium. In this method, the 2-amino benzoic acid (27) is used as starting material, which was converted to 2-azidobenzoic acid (28) via diazotization. Compound (28) is coupled with L-hydroxyproline methylester to give corresponding azidoester (29). The hydroxy group of proline is protected as mesyl ether (30) by treatment of MsCl and triethylamine, which is treated with NaN 3 in DMF to afford the compound (31). The compound (31) is reduced with indium/NH 4 Cl in EtOH to give the 2-amino PBD-5,11-dione or the compound (35) is reduced with HMDST in MeOH to give the 2-azido PBD-5,11-dione (34) in quantitative yields. This ester functionality of (31) has been reduced with DIBAL-H at -78 o C to give the aldehyde (32), which is further reacted with HMDST in MeOH at room temperature offorded the 2-azido PBD imine (33) in good yield (Scheme 6). 
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